Lowe Brockenbrough & Co’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,580
Closed -$1.1M 206
2018
Q2
$1.1M Sell
10,580
-3,575
-25% -$362K 0.16% 127
2018
Q1
$1.39M Buy
14,155
+25
+0.2% +$2.36K 0.21% 114
2017
Q4
$1.2M Sell
14,130
-100
-0.7% -$8.26K 0.17% 121
2017
Q3
$1.09M Sell
14,230
-125
-0.9% -$9.56K 0.17% 124
2017
Q2
$1.12M Sell
14,355
-640
-4% -$45.8K 0.18% 114
2017
Q1
$1.08M Sell
14,995
-130
-0.9% -$8.98K 0.17% 116
2016
Q4
$939K Buy
15,125
+545
+4% +$33.4K 0.16% 121
2016
Q3
$945K Sell
14,580
-975
-6% -$64.9K 0.16% 117
2016
Q2
$984K Sell
15,555
-270
-2% -$15.9K 0.17% 112
2016
Q1
$915K Hold
15,825
0.16% 120
2015
Q4
$850K Sell
15,825
-75
-0.5% -$4.23K 0.14% 126
2015
Q3
$810K Sell
15,900
-250
-2% -$13.5K 0.14% 129
2015
Q2
$910K Sell
16,150
-525
-3% -$33.1K 0.15% 132
2015
Q1
$1.2M Hold
16,675
0.19% 115
2014
Q4
$935K Buy
16,675
+50
+0.3% +$2.61K 0.15% 127
2014
Q3
$819K Buy
16,625
+70
+0.4% +$3.56K 0.13% 133
2014
Q2
$838K Sell
16,555
-25
-0.2% -$1.24K 0.13% 132
2014
Q1
$741K Buy
+16,580
New +$745K 0.12% 134

Other funds holding RMD

Lowe Brockenbrough & Co's RMD Position: Q3 2018 in Review

Lowe Brockenbrough & Co sold out of ResMed (RMD) in Q3 2018, closing a stake of 10,580 shares — an estimated $1.1M sold.

Lowe Brockenbrough & Co first reported a position in RMD in Q1 2014 and held it in 18 quarters. The position peaked at $1.39M in Q1 2018. 497 funds tracked by Wall St. Rank hold RMD as of Q3 2018.

  • Lowe Brockenbrough & Co reported no remaining ResMed position as of Q3 2018 after selling out during the quarter.
  • Lowe Brockenbrough & Co sold 10,580 ResMed shares in Q3 2018, an estimated $1.1M.
  • Lowe Brockenbrough & Co first reported a position in ResMed in Q1 2014 and held it in 18 quarters.
  • Lowe Brockenbrough & Co's ResMed position peaked at $1.39M in Q1 2018.
  • 497 funds tracked by Wall St. Rank held ResMed as of Q3 2018.

Based on Lowe Brockenbrough & Co's 13F filing for Q3 2018, filed 15 Nov 2018.